Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about United BioPharma aggregated by PharmaCompass.com.

    Client Virtual Booth

    UNITED BIOPHARMA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    United BioPharma
    Taiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    45-1 Guangfu N. Rd., Hukou Industrial Park (capital I) Hukou Township, Hsinchu County, 30351
    Telephone
    Telephone
    +886-3-597-9288
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ubp-cdmo.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    NIAID receives the FDA approval to conduct a phase 2 clinical trial with UB-421
    NIAID receives the FDA approval to conduct a phase 2 clinical trial with UB-421

    https://www.prnewswire.com/news-releases/niaidnih-recognizes-the-potency-of-ub-421-against-multi-drug-resistant-hiv-and-receives-the-fda-approval-to-conduct-a-phase-2-clinical-trial-with-ub-421-301615221.html

    PRNEWSWIRE
    31 Aug 2022
    Share Share
    United BioPharma's Study Reveals New Class of Monoclonal Antibody
    United BioPharma's Study Reveals New Class of Monoclonal Antibody

    https://www.prnewswire.com/news-releases/united-biopharmas-study-reveals-new-class-of-monoclonal-antibody-for-effective-relief-of-urticaria-symptoms-301600778.html

    PRNEWSWIRE
    05 Aug 2022
    Share Share
    United BioPharma Receives TFDA Approval for PII IND for UB-221
    United BioPharma Receives TFDA Approval for PII IND for UB-221

    https://www.prnewswire.com/news-releases/united-biopharma-receives-tfda-approval-for-phase-2-ind-for-ub-221-to-treat-chronic-spontaneous-urticaria-301557159.html

    PRNEWSWIRE
    29 May 2022
    Share Share
    United , Shanghai Public Health Clinical Centre and Cheng Kung University UB-621
    United , Shanghai Public Health Clinical Centre and Cheng Kung University UB-621

    https://www.prnewswire.com/news-releases/united-biopharma-shanghai-public-health-clinical-centre-and-cheng-kung-university-partner-on-worlds-first-long-acting-herpes-treatment-ub-621-301402475.html

    PRNEWSWIRE
    18 Oct 2021
    Share Share
    United BioPharma Received IND Approval from China NMPA for UB-621 Ph2 Trial
    United BioPharma Received IND Approval from China NMPA for UB-621 Ph2 Trial

    http://www.unitedbiopharma.com/news_detail.php?id=443

    UNITEDBIOPHARMA
    11 Nov 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search